CoreAge Rx vs boostAGErx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and boostAGErx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make boostAGErx a bad call — it's best for readers who want to check the clinical and pharmacy arrangements and can obtain an itemized medication-and-membership total. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | boostAGErx |
|---|---|---|
| Brief Score | 94/100 (A) | 72/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm complete charge GLP-1 formulation and full charge unconfirmed; terms use a 28-day membership cycle. Earlier $95 observation is historical. Full price detailsCurrent semaglutide formulation and medication-plus-membership quote unknown; earlier listing: From $95/mo (billed every 28 days, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm complete charge GLP-1 formulation and full charge unconfirmed; terms use a 28-day membership cycle. Earlier $145 observation is historical. Full price detailsCurrent tirzepatide formulation and medication-plus-membership quote unknown; earlier listing: From $145/mo (billed every 28 days, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Terms advertise all 50 states plus DC for adults physically in the US; clinical and pharmacy eligibility applies |
| Brand-name access | Not confirmed | Brand or compounded formulation unconfirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
boostAGErx: Current GLP-1 formulations and full charges remain unconfirmed. Terms reference 28-day membership billing; earlier $95/$145 observations are historical.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.